First Time Loading...

Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.078 AUD 4% Market Closed
Updated: May 15, 2024

Wall Street
Price Targets

PER Price Targets Summary
Percheron Therapeutics Ltd

Wall Street analysts forecast PER stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PER is 0.255 AUD with a low forecast of 0.232 AUD and a high forecast of 0.284 AUD.

Lowest
Price Target
0.232 AUD
198% Upside
Average
Price Target
0.255 AUD
227% Upside
Highest
Price Target
0.284 AUD
263% Upside
Percheron Therapeutics Ltd Competitors:
Price Targets
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
44% Upside
PHO
Photocure ASA
61% Upside
300049
Inner Mongolia Furui Medical Science Co Ltd
53% Downside
PFE
Pfizer Inc
13% Upside
300039
Shanghai Kaibao Pharmaceutical Co Ltd
11% Upside
AXSM
Axsome Therapeutics Inc
65% Upside
000538
Yunnan Baiyao Group Co Ltd
16% Upside
OCUL
Ocular Therapeutix Inc
161% Upside

Revenue
Forecast

Revenue Estimate
Percheron Therapeutics Ltd

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -25%. The projected CAGR for the next 3 years is 54%.

-25%
Past Growth
54%
Estimated Growth
Estimates Accuracy
-98%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PER's stock price target?
Price Target
0.255 AUD

According to Wall Street analysts, the average 1-year price target for PER is 0.255 AUD with a low forecast of 0.232 AUD and a high forecast of 0.284 AUD.

What is Percheron Therapeutics Ltd's Revenue forecast?
Projected CAGR
54%

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -25%. The projected CAGR for the next 3 years is 54%.